AbbVie

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

AbbVie hands back phase 1 duties for inflammation drug to Ose

The Big Pharma now wants the French biotech to keep an eye on the asset for a while longer.
James Waldron Dec 8, 2025 5:39am
Aerial view of Montreal Old Port in autumn

AbbVie seeks biotech applicants for Canadian innovation award

Nov 25, 2025 12:00pm
scissor cutting rope

AbbVie to end Calico collab, lay off scientists: Stat

Nov 13, 2025 3:59pm
close up of a beautiful dragonfly

AbbVie halts development of Dragonfly cancer asset in midflight

Oct 29, 2025 1:47pm
ZigZag zigging zagging

Zag Bio emerges with $80M funding for Tregs diabetes candidate

Oct 28, 2025 7:00am
100 dollar bills scattered in the air money inflation concept

AbbVie flags $2.7B R&D hit to brace investors for lower profit

Oct 6, 2025 3:27am